A bivalent compound targeting CCR5 and the mu opioid receptor treats inflammatory arthritis pain in mice without inducing pharmacologic tolerance
Dutta, Raini, Lunzer, Mary M., Auger, Jennifer L., Akgün, Eyup, Portoghese, Philip S., Binstadt, Bryce A.Volume:
20
Language:
english
Journal:
Arthritis Research & Therapy
DOI:
10.1186/s13075-018-1661-5
Date:
December, 2018
File:
PDF, 1.22 MB
english, 2018